Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$172.27 - $223.95 $2.81 Million - $3.65 Million
-16,300 Reduced 61.51%
10,200 $1.84 Million
Q1 2024

May 15, 2024

BUY
$220.09 - $273.15 $3.98 Million - $4.94 Million
18,100 Added 215.48%
26,500 $5.91 Million
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $4.44 Million - $6.37 Million
-24,480 Reduced 74.45%
8,400 $2.11 Million
Q3 2023

Nov 14, 2023

BUY
$240.69 - $338.77 $3.44 Million - $4.84 Million
14,280 Added 76.77%
32,880 $7.95 Million
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $4.05 Million - $5.13 Million
14,900 Added 402.7%
18,600 $6.4 Million
Q1 2023

May 15, 2023

BUY
$220.43 - $278.69 $815,591 - $1.03 Million
3,700 New
3,700 $1.03 Million
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $34,827 - $68,199
-300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $56,253 - $85,194
300 New
300 $67,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.25B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.